Intravesical Administration Of Therapeutic

DRUG NAME: Mitomycin

Corticosteroids have been reported to help with symptoms but their therapeutic value has not been determined. 1,3: ... of mitomycin has been used for intravesical administration. 9,15-17; to prevent precipitation, solution should be freshly prepared and not refrigerated. 18.

  Administration, Therapeutic, Intravesical, Intravesical administration

Category I Vaccine Long Code Descriptors

(For therapeutic or diagnostic injections, see 96372-96379) January 19, 2021 May 4, 2021 July 30, 2021 August 16, 2021 September 3, 2021 October 6, 2021 ... (For intravesical administration of BCG vaccine, see 51720, 90586) New Parenthetical Note Released to AMA Website November 10, 2020 Revised Parenthetical Note

  Administration, Therapeutic, Intravesical, Intravesical administration

DRUG NAME: Leucovorin - BC Cancer

usually administered 24 hours after methotrexate so that it does not interfere with the therapeutic effect of ... • intrathecal administration not recommended. 2 • increases the cytotoxicity and toxicity of fluorouracil. 2. ... Intravesical no information found

  Administration, Therapeutic, Intravesical

DRUG NAME: Vinorelbine - BC Cancer

occur within one hour after drug administration and may be characterized by cough, dyspnea, hypoxemia and interstitial infiltration. Subacute pulmonary reactions may respond to corticosteroid therapy. Oxygen may provide symptomatic relief.

  Administration

DRUG NAME: Oxaliplatin

Oxaliplatin DRUG NAME: Oxaliplatin SYNONYM(S): ACT -078, l OHP, LOHP, oxalatoplatin, oxaliplatinum COMMON TRADE NAME(S): ELOXATIN CLASSIFICATION: Alkylating agent Special pediatric considerations are noted when applicable, otherwise adult provisions apply.

DRUG NAME Temozolomide - BC Cancer

Temozolomide DRUG NAME: Temozolomide SYNONYM(S): TMZ, SCHS2.365, NSC 362856 COMMON TRADE NAME(S): TEMODAL®, TEMODAR® CLASSIFICATION: Alkylating agent. Special pediatric considerations are noted when applicable, otherwise adult provisions apply.